Healthcare

AEON Biopharma (NYSE American: AEON) shares are indicated down 4.58% in pre-market trading at $0.28, despite the company announcing that it has regained compliance with NYSE American's continued listing standards relating to stockholders' equity.

ClearPoint Neuro (NASDAQ:CLPT) shares are indicated down 17.10% in pre-market trading at $12.75, with a day range of $14.65 to $15.53 in Monday's regular session, after the company reported second-quarter results that missed estimates on both revenue and earnings, alongside revised full-year guidance.

IDEXX Laboratories (NASDAQ:IDXX) shares are indicated up 3.73% in pre-market trading at $589.00, extending a 1.02% after-hours gain from Monday, after the company reported second-quarter results that beat Wall Street expectations across revenue and earnings, with shares still trading below their 52-week high of …

Merck (NYSE:MRK) shares are indicated up 1.78% in pre-market trading at $129.99, following the company's second-quarter 2026 earnings report. Merck & Co., known as MSD outside the United States and Canada, is a health care company that provides prescription medicines, vaccines, and biologic therapies …

Novartis (NYSE:NVS) shares were trading down 1.31% at $154.10 intraday, with a day range of $153.02 to $157.10 on volume of 1.28 million shares. The decline reflects sector-wide volatility rather than company-specific weakness, as pharma giants broadly reacted to reports of preliminary merger talks …

Novo Nordisk (NYSE:NVO) shares were trading little changed, down 0.03% near $47.07, with a day range of $46.19 to $47.17 on volume of 9.08 million shares. The stabilization comes after last week's sharp selloff, which sent the stock down as much as 9% to …

Sellas Life Sciences (NASDAQ:SLS) shares are trading sharply higher, up 13.44% at $11.36 intraday, with a day range of $9.80 to $11.37 on volume of 4.99 million shares, extending gains that began Monday driven by institutional buying. After 13F filings showed Opus Capital Group …